Dai Ichi Life Insurance Company, LTD Nektar Therapeutics Transaction History

Dai Ichi Life Insurance Company, LTD

  • $3.54 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019
SELL
$16.91 - $36.27 $205,219 - $440,172
-12,136 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$30.43 - $56.65 $2,890 - $5,381
95 Added 0.79%
12,136 $399,000
Q2 2018

Aug 10, 2018
BUY
$46.25 - $104.45 $556,896 - $1.26 Million
12,041 New
12,041 $588,000

Others Institutions Holding NKTR

# of Institutions
153
Shares Held
131M
Call Options Held
92.7K
Put Options Held
4.9K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $161M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Dai Ichi Life Insurance Company, LTD Portfolio

Follow Dai Ichi Life Insurance Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dai Ichi Life Insurance Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dai Ichi Life Insurance Company, LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email